Ironwood Pharmaceuticals reported $579.94M in Equity Capital and Reserves for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 566.96M 2.12M
Acceleron Pharma XLRN:US $ 718.15M 44.88M
Agios Pharmaceuticals AGIO:US $ 1394.76M 327.05M
Akebia Therapeutics AKBA:US $ 137.15M 37.48M
Alnylam Pharmaceuticals ALNY:US $ 755.89M 97.47M
Amarin AMRN:US $ 642.5M 2.83M
Ardelyx ARDX:US $ 81.43M 36.14M
Astellas Pharma 4503:JP Y 1417622M 34753M
AstraZeneca AZN:LN 39744M 24068M
Astrazeneca AZN:US $ 39744M 24068M
Bluebird Bio BLUE:US $ 870.53M 114.03M
Charles River Laboratories CRL:US $ 2426.57M 108.13M
Coherus Biosciences CHRS:US $ 130.76M 25.46M
Emergent Biosolutions EBS:US $ 1522.7M 21M
Esperion Therapeutics ESPR:US $ -362705000 58.4M
Exact Sciences EXAS:US $ 3457.59M 101.51M
Flexion Therapeutics FLXN:US $ -82377000 26.21M
Halozyme Therapeutics HALO:US $ 281.67M 161.93M
Intercept Pharmaceuticals ICPT:US $ -156.03M 47.16M
Ironwood Pharmaceuticals IRWD:US $ 579.94M 68.18M
Karyopharm Therapeutics KPTI:US $ -125977000 42.84M
Lexicon Pharmaceuticals LXRX:US $ 136.6M 630K
Macrogenics MGNX:US $ 291.44M 27.61M
Moderna Inc MRNA:US 10.12B 3.42B
Myriad Genetics MYGN:US $ 968.6M 66.1M
Pacira Pharmaceuticals PCRX:US $ 718.6M 31.43M
Ptc Therapeutics PTCT:US $ 104.93M 91.65M
Puma Biotechnology PBYI:US $ -10.92M 40.39M
Sarepta Therapeutics SRPT:US $ 469.53M 15.58M
Takeda 4502:JP Y 5323935M 24161M
Ultragenyx Pharmaceutical RARE:US $ 933.67M 38.5M
Vanda Pharmaceuticals VNDA:US $ 493.32M 12.1M
YTE INCY:US $ 3148.66M 212.8M